Connect with us

Press Releases

SOMAÍ Pharmaceuticals launches in Ireland, offering the widest range of cannabis-based medicines to patients

Published

em

Listen to this article

SOMAÍ Pharmaceuticals partners with Georgelle Pharmaceutical to introduce wide range of cannabis-based medicines to Ireland

LISBON, PORTUGAL, September 17, 2024 /EINPresswire.com/ — SOMAÍ Pharmaceuticals (“SOMAÍ”), a leading EU GMP vertically integrated Multinational Operator (MCO) company with a global distribution footprint of the largest and most advanced EU GMP certified portfolio of cannabinoid-containing pharmaceutical extracts, is proud to announce its partnership with Georgelle Pharmaceutical Ltd (“Georgelle”), to bring an innovative range of cannabis-based medicines to patients in Ireland.

This partnership represents a significant milestone for SOMAÍ Pharmaceuticals as it extends its global footprint to Ireland, making it the fifth country to establish a presence, following successful expansions into the UK, Australia, Germany and Poland earlier this year.

Under the terms of the three-year agreement, SOMAÍ will provide a consistent, varied and differentiated portfolio of cannabinoid-containing products to all clinics and doctors prescribing cannabis in Ireland, using Georgelle’s distribution network. Irish patients will initially have access to a range of single-strain THC, CBD and balanced oral solutions.

The product line will later be expanded to include mint-infused oral solutions with different terpene lines, and inhalation extracts with increased terpene levels, all part of SOMAÍ’s Origins and Senses line.

The company is committed to ensuring that Irish patients can access a wide range of cannabis-based medicines with enhanced flavour and tailored terpene blends, effectively addressing their specific needs.

“SOMAÍ is proud to enter Ireland with a great partner in Georgelle. Offering Irish patients a full range of products and options will further expand the demographic that needs medicinal cannabis and has suffered from limited treatment options. Irish patients deserve access, through Georgelle, to SOMAÍ’s dedicated portfolio of cannabis extracts and a wide range of non-irradiated indoor flower lines,” said Michael Sassano, Founder and Interim CEO of SOMAÍ Pharmaceuticals.

“We are excited and proud to partner with SOMAÍ Pharmaceuticals. We have followed the great strides SOMAÍ has made to date and recognized the great potential in the collaboration given our similar attitudes toward patient care. We admire their commitment to innovation and making a positive impact and their dedication to providing a broad range of medicines to meet the diverse needs of patients,” said Daniel O’Brien, CSO of Georgelle Ltd.

About SOMAÍ Pharmaceuticals 

SOMAÍ Pharmaceuticals is a leading EU GMP vertically integrated Multinational Operator (MCO) company with a global distribution presence of the largest and most advanced portfolio of EU GMP certified cannabinoid-containing pharmaceutical extracts.

At SOMAÍ, we are building a leading global brand with the most robust pipeline of innovative cannabis-based therapeutics. We envision a world where people live a healthy lifestyle powered by natural cannabis medicine.

SOMAÍ has state-of-the-art indoor cultivation and production facilities in Lisbon, Portugal, and has global sales teams in the largest medical cannabis markets. We continue to make global brand acquisitions and partnerships that make us one of the few and first vertically integrated European companies in the EU, able to meet the diverse needs of the rapidly growing global cannabis markets.

About Georgelle Pharmacist

A family-owned business, Georgelle has been a leading pharmaceutical wholesaler in Ireland for over 40 years. Georgelle works closely with leading cannabis-based medicines manufacturers to expand its reach in Ireland and provide patients and physicians with a seamless delivery of medicines across the country.

 

____________________________________________________________________________________________________

[Disclaimer: Please note that this text was originally written in Portuguese and is translated into English and other languages ​​using an automatic translator. Some words may differ from the original and typos or errors may occur in other languages.]

____________________________________________________________________________________________________

What do you do with €3 a month? Become one of our Patrons! If you believe that independent cannabis journalism is necessary, subscribe to one of the levels of our Patreon account and you will have access to unique gifts and exclusive content. If there are many of us, we can make a difference with little!

CannaReporter
Editor-in-Chief
Click here to comment
Subscribe
Notify of

0 Comments
Inline feedback
View all comments
Advertise with us!


Watch the Documentary "Patients"

Documentary Patients Laura Ramos help us grow

Mais recentes

Analysis1 hours ago

Is HHC about to be classified as a narcotic under international law?

The United Nations Commission on Narcotic Drugs (CND) will meet in Vienna in March with an agenda item that...

Hemp2 days ago

Infarmed orders the withdrawal of (more) cosmetics containing CBD, but the measure raises doubts about compliance with European regulations

Infarmed – National Authority for Medicines and Health Products IP has ordered the immediate withdrawal from the market of several products...

Opinion4 days ago

The Importance of Women in the Cannabis Industry

The cannabis industry is evolving rapidly, but like many sectors, it has long been dominated by leadership...

Science4 days ago

International Day of Women in Science: What has changed in 100 years?

Can you spot the woman in this photograph, taken at the 5th Congress on Quantum Mechanics in Brussels in 1927? Less than...

Science4 days ago

Jürg Gertsch: “There is definitely a growing interest in cannabis-related research”

The International Medical Cannabis Conference Bern (IMCCB), organized by Professors Jürg Gertsch and Rudolf Brenneisen, aims to...

Science1 weeks ago

What is HHC and what effects can it have on human health?

HHC (hexahydrocannabinol) is a cannabinoid that can be either natural or semi-synthetic, depending on how it is obtained. Although...

Events1 weeks ago

Cannabinoid Translational Science Symposium starts February 10th, exclusively online

The International Cannabinoid Translational Science Symposium will bring together experts to discuss advances in research and therapeutic application...

Interviews2 weeks ago

Mike Jay: “Cannabis was the psychedelic of the 19th century: people would take large doses and have hallucinations and very intense experiences”

Mike Jay is a journalist and cultural historian who has been dedicated to the subject of drugs for over 30 years. He began writing...

International2 weeks ago

US: Curaleaf Donated $250.000 to Donald Trump to Push for Cannabis Reform

Curaleaf, one of the largest cannabis companies in the US, donated $250.000 to President Donald Trump's inauguration ceremony...

Analysis2 weeks ago

Global cannabis market could reach $55,3 billion by 2028

The global cannabis market could reach $55,3 billion by 2028, but the industry is at a...